1
|
Wu F, Zhao X, Wang S, Zhou H, Guo S, Ni S, Yang B, Zhang L, Xu X. Development and validation of a HPLC-MS/MS assay for the determination of lutein concentration in human and rat plasma. ACTA CHROMATOGR 2019. [DOI: 10.1556/1326.2017.00313] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Feng Wu
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing-100730, China
| | - Xiuli Zhao
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing-100730, China
| | - Shumin Wang
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing-100730, China
| | - Hui Zhou
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing-100730, China
| | - Shaojie Guo
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing-100730, China
| | - Siyang Ni
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing-100730, China
| | - Bo Yang
- National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing-100730, China
| | - Lihua Zhang
- Zhejiang Medicine Co. Ltd, Xinchang Pharma. Factory, Zhejiang Xinchang-312500, China
| | - Xinde Xu
- Zhejiang Medicine Co. Ltd, Xinchang Pharma. Factory, Zhejiang Xinchang-312500, China
| |
Collapse
|
2
|
Enhanced cytotoxic and apoptosis inducing activity of lycopene oxidation products in different cancer cell lines. Food Chem Toxicol 2016; 97:265-276. [DOI: 10.1016/j.fct.2016.09.016] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2016] [Revised: 09/10/2016] [Accepted: 09/12/2016] [Indexed: 11/22/2022]
|
3
|
|